US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

VXRT

Vaxart (VXRT)

Vaxart Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VXRT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/30	10 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VXRT	Vaxart Inc
2025/01/30	10 : 05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VXRT	Vaxart Inc
2025/01/28	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VXRT	Vaxart Inc
2025/01/28	22 : 00	GlobeNewswire Inc.	Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors	NASDAQ:VXRT	Vaxart Inc
2025/01/21	23 : 41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VXRT	Vaxart Inc
2025/01/15	03 : 40	AllPennyStocks.com	This California-Based Biotech Found Massive Success Following DSMB Approval	NASDAQ:VXRT	Vaxart Inc
2025/01/14	22 : 00	GlobeNewswire Inc.	Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs	NASDAQ:VXRT	Vaxart Inc
2025/01/14	09 : 55	GlobeNewswire Inc.	Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial	NASDAQ:VXRT	Vaxart Inc
2025/01/01	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VXRT	Vaxart Inc
2024/12/27	23 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VXRT	Vaxart Inc
2024/12/18	06 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VXRT	Vaxart Inc
2024/12/03	06 : 01	GlobeNewswire Inc.	Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate	NASDAQ:VXRT	Vaxart Inc
2024/11/19	22 : 00	GlobeNewswire Inc.	Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VXRT	Vaxart Inc
2024/11/14	06 : 23	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VXRT	Vaxart Inc
2024/11/14	06 : 01	GlobeNewswire Inc.	Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results	NASDAQ:VXRT	Vaxart Inc
2024/11/07	22 : 00	GlobeNewswire Inc.	Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13	NASDAQ:VXRT	Vaxart Inc
2024/10/24	21 : 00	GlobeNewswire Inc.	Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024	NASDAQ:VXRT	Vaxart Inc
2024/10/15	21 : 00	GlobeNewswire Inc.	Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need	NASDAQ:VXRT	Vaxart Inc
2024/10/09	05 : 06	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VXRT	Vaxart Inc
2024/10/09	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VXRT	Vaxart Inc
2024/10/01	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VXRT	Vaxart Inc
2024/10/01	05 : 12	GlobeNewswire Inc.	Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate	NASDAQ:VXRT	Vaxart Inc
2024/08/30	21 : 00	GlobeNewswire Inc.	Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VXRT	Vaxart Inc
2024/08/28	21 : 00	GlobeNewswire Inc.	Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical Dysplasia	NASDAQ:VXRT	Vaxart Inc
2024/08/09	05 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VXRT	Vaxart Inc
2024/08/09	05 : 01	GlobeNewswire Inc.	Vaxart Provides Business Update and Reports Second Quarter 2024 Financial Results	NASDAQ:VXRT	Vaxart Inc
2024/08/02	21 : 00	GlobeNewswire Inc.	Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8	NASDAQ:VXRT	Vaxart Inc
2024/06/20	19 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VXRT	Vaxart Inc
2024/06/18	05 : 05	GlobeNewswire Inc.	Vaxart Provides Business Update	NASDAQ:VXRT	Vaxart Inc
2024/06/17	19 : 02	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VXRT	Vaxart Inc

Showing the most relevant articles for your search:NASDAQ:VXRT

1 2 3 4 5 6 7 8 9 10 次へ >>

Gold vs US Dollar

Health Care Select Sector

BNP Paribas (QX)

Bank of America

American Express

JP Morgan Chase

Verizon Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約